12 December 2016Americas

Boston Scientific sues Nevro over pain treatment system

Medical device company Boston Scientific has filed a complaint against Nevro for allegedly infringing ten of its patents.

The suit, which was filed on Friday, December 9 in the US District Court for the District of Delaware, centres on the Senza spinal cord stimulation system, produced by Nevro.

The main claim of infringement made in the suit was Nevro’s bringing to market of Senza before the patents covering the technology behind the product expire.

Nevro was granted approval by the Food and Drug Administration in May 2015 to treat pain without tingling sensation.

Boston Scientific stated in its complaint: “Boston Scientific has been damaged as a result of Nevro’s infringing conduct and is entitled to recover damages and adequately compensate it for Nevro’s infringement.”

Following the suit, Boston Scientific has asked the court for a judgment that Nevro has infringed claims of its patents.

It has also asked the court to be awarded costs and expenses.

It comes after Nevro itself filed a patent lawsuit against Boston Scientific in November, asserting that Boston Scientific has infringed Nevro's patents covering Senza.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
2 November 2021   Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.

More on this story

Americas
2 November 2021   Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.

More on this story

Americas
2 November 2021   Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.